ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update.

Saved in:
Bibliographic Details
Title: ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update.
Authors: Turkbey B; National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address: turkbeyi@mail.nih.gov., Oto A; Panel Chair, University of Chicago, Chicago, Illinois., Allen BC; Panel Vice-Chair, Duke University Medical Center, Durham, North Carolina., Akin O; Memorial Sloan Kettering Cancer Center, New York, New York., Alexander LF; Mayo Clinic, Jacksonville, Florida., Ari M; The University of Chicago, Chicago, Illinois, Primary care physician., Froemming AT; Mayo Clinic, Rochester, Minnesota., Fulgham PF; Urology Clinics of North Texas, Dallas, Texas; American Urological Association., Gettle LM; University of Wisconsin, Madison, Wisconsin., Maranchie JK; UPMC, Pittsburgh, Pennsylvania; American Urological Association., Rosenthal SA; Sutter Medical Group, Sacramento, California; Commission on Radiation Oncology., Schieda N; Ottawa Hospital Research Institute and the Department of Radiology, The University of Ottawa, Ottawa, Ontario, Canada., Schuster DM; Emory University, Atlanta, Georgia; Commission on Nuclear Medicine and Molecular Imaging., Venkatesan AM; The University of Texas MD Anderson Cancer Center, Houston, Texas., Lockhart ME; Specialty Chair, University of Alabama at Birmingham, Birmingham, Alabama.
Corporate Authors: Expert Panel on Urologic Imaging
Source: Journal of the American College of Radiology : JACR [J Am Coll Radiol] 2023 May; Vol. 20 (5S), pp. S164-S186.
Publication Type: Review; Practice Guideline; Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101190326 Publication Model: Print Cited Medium: Internet ISSN: 1558-349X (Electronic) Linking ISSN: 15461440 NLM ISO Abbreviation: J Am Coll Radiol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-349X
DOI:10.1016/j.jacr.2023.02.012